NEW YORK (GenomeWeb News) – Bioanalytical testing company Eurofins Scientific today said it has signed a definitive agreement to purchase esoteric reference laboratory ViraCor-IBT Laboratories for about $255 million.

Eurofins is purchasing VIBT from majority owner Ampersand Capital, a private equity firm, and other shareholders. The deal is anticipated to close within 60 days, Eurofins said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genomic analysis of high-grade serous ovarian cancer, and more.

The new Riken president outlines some of his plans for the institute.

The Guardian discusses whether big science projects are worth the loss of resources available for other scientific pursuits.

An NEJM update from the ClinVar team highlights the difficulties of interpreting genetic variants.